2-11669541-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The ENST00000306928.6(NTSR2):ā€‹c.589C>Gā€‹(p.Leu197Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000303 in 1,420,994 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000044 ( 0 hom., cov: 31)
Exomes š‘“: 0.000029 ( 0 hom. )

Consequence

NTSR2
ENST00000306928.6 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.522
Variant links:
Genes affected
NTSR2 (HGNC:8040): (neurotensin receptor 2) The protein encoded by this gene belongs to the G protein-coupled receptor family that activate a phosphatidylinositol-calcium second messenger system. Binding and pharmacological studies demonstrate that this receptor binds neurotensin as well as several other ligands already described for neurotensin NT1 receptor. However, unlike NT1 receptor, this gene recognizes, with high affinity, levocabastine, a histamine H1 receptor antagonist previously shown to compete with neurotensin for low-affinity binding sites in brain. These activities suggest that this receptor may be of physiological importance and that a natural agonist for the receptor may exist. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.15164486).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NTSR2NM_012344.4 linkuse as main transcriptc.589C>G p.Leu197Val missense_variant 1/4 ENST00000306928.6 NP_036476.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NTSR2ENST00000306928.6 linkuse as main transcriptc.589C>G p.Leu197Val missense_variant 1/41 NM_012344.4 ENSP00000303686 P1

Frequencies

GnomAD3 genomes
AF:
0.0000439
AC:
6
AN:
136570
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000763
Gnomad OTH
AF:
0.000535
GnomAD3 exomes
AF:
0.0000431
AC:
7
AN:
162384
Hom.:
0
AF XY:
0.0000329
AC XY:
3
AN XY:
91170
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000167
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000383
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000288
AC:
37
AN:
1284424
Hom.:
0
Cov.:
40
AF XY:
0.0000269
AC XY:
17
AN XY:
632608
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000158
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000275
Gnomad4 OTH exome
AF:
0.0000590
GnomAD4 genome
AF:
0.0000439
AC:
6
AN:
136570
Hom.:
0
Cov.:
31
AF XY:
0.0000154
AC XY:
1
AN XY:
64872
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000763
Gnomad4 OTH
AF:
0.000535
Bravo
AF:
0.0000264
ExAC
AF:
0.0000261
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 24, 2023The c.589C>G (p.L197V) alteration is located in exon 1 (coding exon 1) of the NTSR2 gene. This alteration results from a C to G substitution at nucleotide position 589, causing the leucine (L) at amino acid position 197 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
12
DANN
Benign
0.92
DEOGEN2
Benign
0.030
T
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.28
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.57
T
M_CAP
Benign
0.0096
T
MetaRNN
Benign
0.15
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.51
N
MutationTaster
Benign
0.96
N
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-0.39
N
REVEL
Benign
0.042
Sift
Benign
0.18
T
Sift4G
Benign
0.48
T
Polyphen
0.76
P
Vest4
0.036
MutPred
0.51
Gain of glycosylation at S199 (P = 0.2065);
MVP
0.62
MPC
0.15
ClinPred
0.051
T
GERP RS
2.5
Varity_R
0.13
gMVP
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs774566763; hg19: chr2-11809667; API